Nucleate Germany / Global Virtual Activator 2026–2027
Nucleate
HIGH
T3
Founder
Strategy Notes
Global Virtual option removes location barrier pre-EDITH. Life sciences focus fits computational pharmacology. Post-EDITH, Germany chapter directly accessible. Imprint MVP + CCT preprints satisfy 'preliminary POC data' requirement.
Key Materials
Application via nucleate.org/activator. Technology/project description, team composition, scientific foundation.
Gate / Eligibility
Academic trainee (PhD/MS/Postdoc/MD) or early professional. No equity taken. MSc student qualifies.